Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wesure Global Tech Ltd. M&A Activity 2026

May 27, 2026

7111_rns_2026-05-27_befa0347-46a5-4e46-9dce-9a4c09937c6c.pdf

M&A Activity

Open in viewer

Opens in your device viewer

This is an unofficial AI generated translation of the official Hebrew version and has no binding force. The only binding version is the official Hebrew version. For more information, please review the legal disclaimer.

WESURE GLOBAL TECH LTD
WESURE GLOBAL TECH LTD
Number in the Register: 515559169
To: Israel Securities Authority
To: Tel Aviv Stock Exchange Ltd. T121 (Public)
Filed via MAGNA: 27/05/2026
www.isa.gov.il
www.tase.co.il
Reference number: 2026-01-049109

Immediate report for general material information

Explanation: This form must not be used when there is a form adapted to the reported event.

This reporting form is intended for material reports for which there is no appropriate dedicated form.

Issuance results must be reported on Form T20 and not on this form.

Reports on rating of BONDS or corporate rating must be submitted via Form T125.

Nature of the event: Immediate report

Reference numbers of previous reports on the subject: _, _, ____.

Further to the report of WESURE GLOBAL TECH LTD (the "Company") dated May 25, 2026 (reference 2026-01-04804) regarding the Company's approach to the board of directors of Ayalon Insurance Company Ltd. ("Ayalon Insurance") in a written proposal, whereby the Company proposed to the board of directors of Ayalon Insurance to commence negotiations with it in connection with a possible acquisition of all the shares of the insurance agencies, Ayalon Ne'emanim Insurance Agency Ltd. and Nechonim Insurance Agency Ltd. (the "Agencies") by the Company, or at least 80% thereof (the "Approach"), on May 27, 2026 Ayalon Insurance reported that on May 26, 2026 the board of directors of Ayalon Insurance decided to appoint the audit committee of Ayalon Insurance for the purpose of examining the Company's proposal (the "Committee") and to grant it the authorities required for the performance of its role as follows: 1. To examine whether to enter into negotiations with the Company regarding the Approach, taking into account the economic, business and operational implications of the proposed engagement under the Approach; 2. To act at its discretion and take any course of action as it deems appropriate in connection with the Approach, subject to any law including (but not limited to) examining the terms of the Company's proposal, examining alternatives to the Company's proposal to the extent it deems appropriate, conducting negotiations on the terms of a potential transaction that may arise from the Approach, itself or through advisers, and approving or rejecting the Company's proposal; 3. To authorize the Committee to appoint a team of two to three of the Committee members to lead on its behalf the negotiation process. 4. To determine the methods of conducting the negotiations with the Company. 5. To authorize the Committee to determine its working procedures, including with respect to the attendees of its meetings and the parties to whom information and documents may be transferred; 6. To authorize the Committee to appoint independent external advisers (economic and legal and, as required, additional professional advisers); 7. The Committee, to the extent required in its discretion and subject to any law, will be assisted by members of the management of Ayalon Insurance in the course of its work, including for the purpose of locating external advisers, transferring materials and receiving information, and the like. 8. The Committee will update the board of directors of Ayalon Insurance regarding its recommendation concerning entering into negotiations regarding the Company's proposal, and upon completion of its work the Committee will submit to the board of directors of Ayalon Insurance its decisions and conclusions and will recommend to the board of directors of Ayalon Insurance any possible course of action it determines in accordance with the authorities granted to it. It is clarified that the Company's plans regarding the conduct of negotiations with Ayalon Insurance concerning the acquisition of the Agencies, and/or the Company's entering into a transaction, insofar as the Committee recommends conducting negotiations and these advance to a transaction, constitute forward-looking information, as defined in the Securities Law, 1968, relating to future events the realization of which is uncertain. The information as stated above is based on information in the Company's possession and on the Company's existing plans and assessments as of this date. Such plans of the Company may not materialize or may materialize in a materially different manner, due to events that cannot be assessed in advance and are not under the Company's full control, including failure of the negotiations to mature into a binding agreement and/or approvals required by the competent organs of the Company and of Ayalon Insurance and/or failure to obtain regulatory approvals (to the extent required) and approvals of other parties.

A file is attached ____

The Company is not a shell company as defined in the TASE Regulations

The date on which the corporation first became aware of the event: 27/05/2026 at: 09:45

Details of the signatories authorized to sign on behalf of the corporation:


This is an unofficial AI generated translation of the official Hebrew version and has no binding force. The only binding version is the official Hebrew version. For more information, please review the legal disclaimer.

Name of signatory Position
1 Emil Weinshall Chairman of the Board of Directors
2 Nitzan Tzair Harim Chief Executive Officer

Explanation: According to Regulation 5 of the Securities Regulations (Periodic and Immediate Reports), 1970, a report filed pursuant to these regulations shall be signed by those authorized to sign on behalf of the corporation. The Staff position on the subject can be found on the Authority's website: Click here.

Reference numbers of previous documents on the subject (the mention does not constitute inclusion by way of reference):

Securities of the corporation are listed for trading on the Tel Aviv Stock Exchange

Date of last form structure update: 06/08/2024

Short name: WESURE GLOBAL TECH

Address: Derech HaSharon12, Kfar Saba4427125 Telephone: 09-9780000, 052-4516273Fax:

E-mail: [email protected] Company website: www.we-sure.co.il

Previous names of reporting entity: Heart Digital Ltd.

Name of electronic reporter: Dvir Sofer Moran Position: Legal Counsel and Company Secretary Name of employing company: Address: Derech Aba Hillel Silver 12, Ramat Gan5250606 Telephone: 09-9780000 Fax: E-mail: [email protected]